Harbert Fund Advisors’s Bio-Techne TECH Stock Holding History

Harbert Fund Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$772K	–	96
2023 Q4	$772K	Buy	+10,000	New	+$659K	0.53%	50

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Harbert Fund Advisors's TECH Position: Q1 2024 in Review

Harbert Fund Advisors sold out of Bio-Techne (TECH) in Q1 2024, closing a stake of 10,000 shares — an estimated $772K sold.

Harbert Fund Advisors first reported a position in TECH in Q4 2023 and held it in 1 quarter. The position peaked at $772K in Q4 2023. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

Harbert Fund Advisors reported no remaining Bio-Techne position as of Q1 2024 after selling out during the quarter.
Harbert Fund Advisors sold 10,000 Bio-Techne shares in Q1 2024, an estimated $772K.
Harbert Fund Advisors first reported a position in Bio-Techne in Q4 2023 and held it in 1 quarter.
Harbert Fund Advisors's Bio-Techne position peaked at $772K in Q4 2023.
557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Harbert Fund Advisors's 13F filing for Q1 2024, filed 15 May 2024.